L'Oréal Cell BioPrint: Proteomic Skin Readout in ~5 Minutes, Now Scaling via Lancôme
L'Oréal's Cell BioPrint (with NanoEntek) reads skin protein biomarkers from a tape strip in ~5 min for biological-age + ingredient-response scoring. Debuted CES 2025; Lancôme at-scale rollout from late March 2026 across 9 countries.
TL;DR — Cell BioPrint (L'Oréal + NanoEntek): microfluidic lab-on-a-chip reads skin protein biomarkers from a facial tape strip in ~5 min → outputs biological-age estimate + ingredient (e.g. retinol) responsiveness. Debuted CES 2025; Lancôme at-scale rollout from late March 2026, first batch to 9 countries.
Proteomics replacing imaging at the point of sale.
Pipeline
| Step | What happens |
|---|---|
| 1 | A tape strip is pressed to the cheek/jaw, then dipped in buffer |
| 2 | It's loaded into a microfluidic "lab-on-a-chip" cartridge (NanoEntek) |
| 3 | In ~5 minutes it reads protein biomarkers (FLG2, TG3, IDE, LCN1, YKL40) |
| 4 | It outputs a skin "biological age" + how well ingredients like retinol will work |
Facts
- Time: ~5 minutes (Engadget).
- Hardware: NanoEntek microfluidic lab-on-a-chip; tape-strip sampling; works over sunscreen (per L'Oréal's Guive Balooch).
- Timeline: unveiled CES 2025 (Jan 6, 2025); Lancôme at-scale launch from late March 2026; first batch to 9 countries (KoreaBiomed).
Significance
Shifts in-store diagnostics from descriptive (imaging/questionnaire) to predictive (biomarker-based ingredient matching). Barbara Lavernos, L'Oréal Deputy CEO (R&I): "an exclusive microfluidic lab-on-a-chip technology coupled with our century-long skin science leadership."
FAQ
Core spec?
~5-minute proteomic readout from a tape strip via NanoEntek lab-on-a-chip.
Output?
Skin biological-age estimate + ingredient (retinol) responsiveness.
Launch status?
CES 2025 debut; Lancôme at-scale rollout from late March 2026 (9 countries).
Biomarkers?
Reported as FLG2, TG3, IDE, LCN1, YKL40 (gene list from hands-on/patent sources, not L'Oréal PR).
Sources: Engadget, Cosmetics Business, WWD, KoreaBiomed (2026 rollout).
Image: Shixart1985, CC BY 2.0, via Wikimedia Commons.
← Back to all posts